alendronate has been researched along with Hyperthyroid in 5 studies
alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.
| Excerpt | Relevance | Reference |
|---|---|---|
| "To evaluate the efficacy and safety of alendronate for the treatment of osteoporosis/osteopenia secondary to hyperthyroidism." | 9.16 | [Clinical application of alendronate for osteoporosis/osteopenia secondary to hyperthyroidism]. ( Shen, FX; Yang, LJ; Zhang, HL; Zheng, JC, 2012) |
| " The aim of the present study was to evaluate the effects of treatment with alendronate in patients affected by hyperthyroidism and osteoporosis." | 7.69 | Effects of alendronate on bone loss in pre- and postmenopausal hyperthyroid women treated with methimazole. ( Affinito, P; Arlotta, F; Cascone, E; Di Carlo, C; Lupoli, G; Nappi, C; Nuzzo, V; Vitale, G; Vollery, M, 1996) |
| "To evaluate the efficacy and safety of alendronate for the treatment of osteoporosis/osteopenia secondary to hyperthyroidism." | 5.16 | [Clinical application of alendronate for osteoporosis/osteopenia secondary to hyperthyroidism]. ( Shen, FX; Yang, LJ; Zhang, HL; Zheng, JC, 2012) |
| " The aim of the present study was to evaluate the effects of treatment with alendronate in patients affected by hyperthyroidism and osteoporosis." | 3.69 | Effects of alendronate on bone loss in pre- and postmenopausal hyperthyroid women treated with methimazole. ( Affinito, P; Arlotta, F; Cascone, E; Di Carlo, C; Lupoli, G; Nappi, C; Nuzzo, V; Vitale, G; Vollery, M, 1996) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (40.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yang, LJ | 1 |
| Shen, FX | 1 |
| Zheng, JC | 1 |
| Zhang, HL | 1 |
| Fittipaldi, MR | 2 |
| Fonderico, F | 2 |
| Vitale, G | 2 |
| Ciccarelli, A | 1 |
| Lupoli, GA | 2 |
| Cascella, T | 1 |
| Panico, A | 2 |
| Lupoli, G | 3 |
| Colarusso, S | 1 |
| Di Micco, L | 1 |
| Cavallo, A | 1 |
| Costa, L | 1 |
| Paglione, A | 1 |
| Yamamoto, M | 1 |
| Markatos, A | 1 |
| Seedor, JG | 1 |
| Masarachia, P | 1 |
| Gentile, M | 1 |
| Rodan, GA | 1 |
| Balena, R | 1 |
| Nuzzo, V | 1 |
| Di Carlo, C | 1 |
| Affinito, P | 1 |
| Vollery, M | 1 |
| Cascone, E | 1 |
| Arlotta, F | 1 |
| Nappi, C | 1 |
3 trials available for alendronate and Hyperthyroid
| Article | Year |
|---|---|
[Clinical application of alendronate for osteoporosis/osteopenia secondary to hyperthyroidism].
Topics: Adult; Alendronate; Bone Density; Bone Density Conservation Agents; Bone Diseases, Metabolic; Female | 2012 |
Osteoporosis treatment in elderly hyperthyroid male patients.
Topics: Aged; Alendronate; Antithyroid Agents; Bone Density; Drug Therapy, Combination; Femur Neck; Humans; | 2002 |
[Methimazole versus methimazole and diphosphonates in hyperthyroid and osteoporotic patients].
Topics: Aged; Alendronate; Alkaline Phosphatase; Antithyroid Agents; Bone Density; Calcium; Case-Control Stu | 2005 |
2 other studies available for alendronate and Hyperthyroid
| Article | Year |
|---|---|
The effects of the aminobisphosphonate alendronate on thyroid hormone-induced osteopenia in rats.
Topics: Alendronate; Animals; Bone Diseases, Metabolic; Bone Remodeling; Bone Resorption; Diphosphonates; Di | 1993 |
Effects of alendronate on bone loss in pre- and postmenopausal hyperthyroid women treated with methimazole.
Topics: Adult; Alendronate; Bone Density; Female; Humans; Hyperthyroidism; Methimazole; Middle Aged; Osteoca | 1996 |